Spots Global Cancer Trial Database for Evaluation of Methods for the Determination of Chromogranin A in Routine Blood Samples
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Evaluation of Methods for the Determination of Chromogranin A in Routine Blood Samples
Official Title: Evaluation of Methods for the Determination of Chromogranin A in Routine Blood Samples
Study ID: NCT01216267
Conditions
Study Description
Brief Summary: The goal of this study is to compare several methods for measurement of Chromogranin A in their ability to serve as a marker for disease activity in patients with neuroendocrine tumors. Further, in a subgroup, we will determine if taking a proton pump inhibitor affects Chromogranin A levels.
Detailed Description: Patient group: patients with neuroendocrine tumors (active or inactive) Healthy volunteers
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: Yes
Locations
London Health Sciences Center and St. Joseph's Health Care, London, Ontario, Canada
Contact Details
Name: Stan Van Uum, MD PhD
Affiliation: Western University, Canada
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
